Evidence map›Paper›PMID 27376894›Full record

ArticleMolecular biotechnology2016

SYBR Green II Dye-Based Real-Time Assay for Measuring Inhibitor Activity Against HIV-1 Reverse Transcriptase.

Chakradhar Kokkula, Navaneethan Palanisamy, Malin Ericstam, Johan Lennerstrand

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Chakradhar KokkulaSection of Virology, Department of Medical Sciences, Uppsala University, Dag Hammarskjölds väg 17, 75185, Uppsala, Sweden.
Navaneethan PalanisamySection of Virology, Department of Medical Sciences, Uppsala University, Dag Hammarskjölds väg 17, 75185, Uppsala, Sweden.
Malin EricstamSection of Virology, Department of Medical Sciences, Uppsala University, Dag Hammarskjölds väg 17, 75185, Uppsala, Sweden.
Johan LennerstrandSection of Virology, Department of Medical Sciences, Uppsala University, Dag Hammarskjölds väg 17, 75185, Uppsala, Sweden. Johan.Lennerstrand@medsci.uu.se.
Uppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are arrays of in vitro assays to quantify the activity of HIV-1 reverse transcriptase (HIV-1 RT). These assays utilize either chemically customized/labelled nucleotides, or TaqMan probes, or radiolabeled nucleotides/primers. Although several real-time PCR assays exist commercially for measuring the RT activity, which are usually used for quantifying the viral titres, these assays are not optimized for measuring the inhibitory concentrations (IC50) of HIV-1 RT inhibitors. Moreover, a recently established inorganic pyrophosphate-coupled enzyme assay cannot be employed for studying nonphosphorylated nucleoside reverse transcriptase inhibitors (NRTIs). In the present study, we have developed a novel one-step assay with native nucleotide substrates and SYBR Green II dye to determine IC50 values of triphosphorylated NRTIs against HIV-1 RT. Using exact batches of wild-type and mutant RT, and triphosphorylated NRTIs, we showed that our method gave IC50 values for inhibitors similar to that of an earlier published colorimetric assay with BrdUTP substrate (CABS). Our assay should be suitable for high-throughput screening of antiretroviral drugs and could also be suitable for studying drug resistance profiles. Additionally, we also used our assay to study inhibition by AZT in its nonphosphorylated form by supplementing the reaction mixture with necessary kinases and ATP.

Indexed as

DNA PrimersHigh-Throughput Screening AssaysHIV-1HIV Reverse TranscriptaseHumansMutationOrganic ChemicalsPhosphorylationReal-Time Polymerase Chain ReactionReverse Transcriptase InhibitorsZidovudineDNA PrimersHIV Reverse TranscriptaseOrganic Chemicalsreverse transcriptase, Human immunodeficiency virus 1Reverse Transcriptase InhibitorsSYBR Green IIZidovudineHIV-1 reverse transcriptase (HIV-1 RT)IC50 concentrationsNRTIsResistanceSYBR Green II dye

Identifiers

PMID27376894
OpenAlexW2466734175

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.